[1]Crew KD, Neugut AI. Epidemiology of gastric cancer[J]. World J Gastroenterol, 2006, 12(3): 354-362.
[2]Sánchez-Hidalgo M, Lee M, de la Lastra CA, et al. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines [J]. J Pineal Res, 2012, 53(4): 366-373.
[3]Tam CW, Shiu SY. Functional interplay between melatonin receptormediated antiproliferative signaling and androgen receptorsignaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer[J]. J Pineal Res, 2011, 51(3):297-312.
[4]Konturek PC, Konturek SJ, Burnat G, et al. Dynamic physiological and molecular changes in gastric ulcer healing achieved by melatonin and its precursor L-tryptophan in rats[J]. J Pineal Res, 2008, 45(2):180-190.
[5]Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy[J]. Curr Top Med Chem, 2002, 2(2): 113-132.
[6]Xu L, Liu H, Zhang H, et al. Growth-inhibitory activity of melatoninon murine foregastric carcinom a cells in vitro and the underlying molecular mechanism[J]. Anat Rec, 2013, 296:914-920.
[7]Liu H, Jiang JH, Xu L, et al. Effect of melatonin on proliferation inhibition and apoptosis induction in the murine foregastric carcinoma cell in vivoandin vitro[J]. Acta Anatomica Sinica, 2011, 42(6): 792-797.(in Chinese)
刘卉,蒋继浩,徐丽,等. 褪黑素体内外对小鼠前胃癌细胞的增殖抑制与凋亡诱导作用[J]. 解剖学报, 2011, 42(6): 792-797.
[8]Liu H, Xu L, Wei JE, et al. Role of CD4+ CD25+ regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro[J]. Anat Rec, 2011, 294(5):781-788.
[9]Cutando A, Aneiros-Fernández J, Aneiros-Cachaza J, et al. Melatonin and cancer: current knowledge and its application to oral cavity tumours[J]. J Oral Pathol Med, 2011, 40(8):593-597.
[10]Kobayashi Y, Itoh MT, Kondo H, et al. Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer[J]. J Pineal Res, 2003, 35(2): 71-74.
[11]Kanishi Y, Kobayashi Y, Noda S, et al. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines[J]. J Pineal Res, 2000, 28(4): 227-233.
[12]Winczyk K, Pawlikowski M, Lawnicka H, et al. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl] propanamide on murine Colon 38 cancer growth in vitro and in vivo[J]. Neuro Endocrinol Lett, 2002, 23(Suppl 1): 50-54.
[13]Souza AV, Visconti MA, Castrucci AM. Melatonin biological activity and binding sites in human melanoma cells[J]. J Pineal Res, 2003, 34(4): 242-248.
[14]Motilva V, Cabeza J, Alarcon de la Lastra C. New issues about melatonin and its effects on the digestive system[J]. Curr Pharm Des, 2001, 7(10): 909-931.
[15]Kim JH, Jeong SJ, Kim B, et al. Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells[J]. J Pineal Res, 2012, 52(2): 244-252.
[16]Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy[J].Cell Signal, 2002, 14(5): 381-395.
[17]Lee HY, Crawley S, Hokari R, et al. Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway[J]. Int J Oncol, 2010, 36(4):941-953.
[18]Cui P, Yu M, Luo Z, et al. Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells bymelatonin[J]. J Pineal Res, 2008, 44(1):107-114.
|